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S-nitrosylation (formation of a thionitrite group in cysteines, R-S-N=O) has 
emerged as an important reversible post-translational modification involved in many 
cell signalling processes related with nitric oxide production, and can even represent a 
new paradigm in signal transduction due to some of its particular features.
The “biotin switch” technique allows the replacement of S-nitrosylation with a 
more stable biotinylation that allows easy purification of the modified proteins and has 
been used to study several S-nitrosoproteomes, as well as to detect the modification 
in individual proteins. However, this technique still bears limitations, especially in 
physiological or pathophysiological settings, due to its reduced sensitivity.
We have developed a “fluorescent switch” technique that replaces the S-nitrosylation 
by a fluorescent label. This approach coupled with 2-DE has allowed us to greatly 
reduce the amount of starting protein extract while maintaining the number of identified 
proteins. We have applied it to endothelial cells treated with a nitrosylating agent, as well 
as to identify proteins that are endogenously S-nitrosylated in activated macrophages 
when the denitrosylating activity of thioredoxin is inhibited. This approach can be an 
advantage to study in vivo samples where starting material is limited.
In a different approach, we have greatly increased the number of identified proteins 
and located S-nitrosylation sites by applying a “second-generation proteomics” 
approach to the biotin switch: biotinylated proteins were digested, and peptides were 
purified using an avidin column and identified by LC-ESI-MS/MS. We have created a 
collaborative team (“nitrosoteam”) to implement these methodologies and compare the 
S-nitrosoproteomes in different biological systems, human and plants, in order to get a 
deeper knowledge in the appearance and functional relevance of this modification.
